Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07422987 · ClinicalTrials.gov registry record

GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women

A clinical trial of Body Composition and GLP-1, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT07422987: Recruiting study of Body Composition and GLP-1, sponsored by University of Kansas Medical Center.

NCT07422987 is a study of Body Composition and GLP-1 that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 50 participants, below the 114-participant average among 20 other Body Composition trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07422987, a study of Body Composition and GLP-1, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.

Primary Outcome

Assess changes in body weight by measuring weight on a calibrated scale

Study Locations (1)

Kansas

  • The University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-02-12
Est. Completion 2027-06-30
University of Kansas Medical Center

408 total trials

What NCT07422987 shows while recruiting

NCT07422987 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 114-participant average among 20 other Body Composition trials with a reported enrollment target (56% lower).

The record links to 4 conditions, with Body Composition appearing as the primary indexed condition, and to 0 interventions.

NCT07422987 reports a single indexed study location in Kansas.

Frequently Asked Questions

What is clinical trial NCT07422987 about?

NCT07422987 is a clinical study titled "GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women". This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.

What is the current status of trial NCT07422987?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-02-12. Estimated completion is 2027-06-30.

What conditions does trial NCT07422987 study?

This clinical trial studies the following conditions: Body Composition, GLP-1, Muscle Function, Estrogen Level.

Who is sponsoring clinical trial NCT07422987?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07422987 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Composition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07422987's enrollment target sits among peer trials

50 13th of 20 higher than 8 of 20 other Body Composition trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Body Composition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07422987, the US trial registry maintained by the National Library of Medicine. NCT07422987 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.